-------------------- All post are my opinion. Do your own DD. Who's clicking your buy/sell button!? Posts: 7800 | From: Virginia | Registered: May 2006
| IP: Logged |
-------------------- All post are my opinion. Do your own DD. Who's clicking your buy/sell button!? Posts: 7800 | From: Virginia | Registered: May 2006
| IP: Logged |
-------------------- All post are my opinion. Do your own DD. Who's clicking your buy/sell button!? Posts: 7800 | From: Virginia | Registered: May 2006
| IP: Logged |
-------------------- All post are my opinion. Do your own DD. Who's clicking your buy/sell button!? Posts: 7800 | From: Virginia | Registered: May 2006
| IP: Logged |
posted
ACTC -- Advanced Cell Technology, Inc. Com ($0.001) Search for Dun & Bradstreet reports on this company.
Address: 1201 Harbor Bay Parkway Alameda, CA 94502 USA
Website: http://www.advancedcell.com Phone: (510) 748-4900 Business Description: Not Available Primary State of Incorporation: Delaware Country of Incorporation: USA
Officers: William M. Caldwell IV, CEO
Fiscal Year End: December 31
CIK: 0001140098
Outstanding Shares: 47,232,136 as of 2007-03-12
Estimated Market Cap: 46.287M as of 2007-04-09 (based on Outstanding Shares as of 2007-03-12) Number of Shareholders of Record: 3,000 as of 2007-03-19
-------------------- All post are my opinion. Do your own DD. Who's clicking your buy/sell button!? Posts: 7800 | From: Virginia | Registered: May 2006
| IP: Logged |
-------------------- All post are my opinion. Do your own DD. Who's clicking your buy/sell button!? Posts: 7800 | From: Virginia | Registered: May 2006
| IP: Logged |
just the begining imo. Interview shows that these guys are still at the starting gate but the potential is certainly worth keeping an eye on.
-------------------- All post are my opinion. Do your own DD. Who's clicking your buy/sell button!? Posts: 7800 | From: Virginia | Registered: May 2006
| IP: Logged |
posted
i'm playing this long term. goes up flip out half, goes back down buy more. held this level when i thought for sure it would hit into the .60s. looking for another swing soon. as politics move along stem cell research and the new elections this company (imo) will publicize every angle they can to make a buck. The last interview imo was very honest saying they are still at the starting gate and the potential is pretty good. my call is to play on the momo and take advantage of the flips. - jmho.
-------------------- All post are my opinion. Do your own DD. Who's clicking your buy/sell button!? Posts: 7800 | From: Virginia | Registered: May 2006
| IP: Logged |
Coulda sworn it closed at .78 didn't see an aftermarket bump.
nice hold on the pps for today.
-------------------- All post are my opinion. Do your own DD. Who's clicking your buy/sell button!? Posts: 7800 | From: Virginia | Registered: May 2006
| IP: Logged |
**********: ECMV, IOTN, NURO, TVIA, ACTC, AGSI Have Also Been Removed From Naked Short List Today 2/22/2007... The company, formerly known as A.C.T. Holdings, Inc., was founded in 1994 and is headquartered in Alameda, California. With 33.41 million shares outstanding and 812,538 shares declared short as of January 2007, there is no longer a failure to deliver in shares of ACTC.
http://biz.yahoo.com/ap/070410/congress_stem_cells.html?.v=1 AP Bush Would Veto Stem Cell Research Bill Tuesday April 10, 11:38 am ET By Laurie Kellman, Associated Press Writer White House: Bush Would Veto Bill Subsidizing Stem Cell Research
WASHINGTON (AP) -- President Bush will again veto a bill to subsidize stem cell research using human embryos, but would sign an alternative that permits public funding for studies on embryos incapable of developing into fetuses, the White House said Tuesday.
NEW YORK (AP) -- The Senate is scheduled to take up legislation on Tuesday related to the funding of embryonic stem cell research. The legislation up for debate would lift President Bush's 2001 ban on taxpayer-funded research of embryonic stem cells developed after that time.
[ April 14, 2007, 04:37: Message edited by: BooDog ]
-------------------- All post are my opinion. Do your own DD. Who's clicking your buy/sell button!? Posts: 7800 | From: Virginia | Registered: May 2006
| IP: Logged |
posted
Advanced Cell Technology, Inc.'s Q4/06 Analyst Review Issued by Scimitar Equity Research, Inc.
Apr 18, 2007 09:00:00 (ET)
BOSTON, April 18, 2007 /PRNewswire via COMTEX/ -- Scimitar Equity Research, Inc. today issued a Q4/06 Analyst Review on Advanced Cell Technology, Inc. (ACTC, Trade ) entitled, "Translating Stem Cell Development into Therapeutic Outcomes."
Advanced Cell Technology (ACT) is a biotechnology company applying human embryonic stem (hES) cell technology in the emerging field of regenerative medicine. ACT is developing novel stem cell-based treatments and cures to target a variety of serious diseases and injuries. ACTC's lead therapeutic development programs include stem cell based treatments for retinal disease such as macular degeneration; diseases of the blood, heart and circulatory system, and dermatological treatments for repair of skin damage from surgery, wounds and burns. ACT has entered development partnerships with leading institutions, and is pursuing additional partnerships with leading biotechnology companies and organizations worldwide. ACTC has announced plans to file in 2007 its first Investigational New Drug Application (IND) with the FDA treat the eye condition known as macular degeneration.
The analyst research review of ACTC is available on Scimitar's website: www.scimitarequity.com .
About Advanced Cell Technology, Inc.
Advanced Cell Technology, Inc. is a biotechnology company applying embryonic stem cell technology in the emerging field of regenerative medicine. The company operates facilities in Alameda, California and Worcester, Massachusetts. For more information, please visit: www.advancedcell.com . For investor-specific information and resources, visit
Scimitar Equity Research, Inc. provides sponsored equity research of the healthcare industry for the institutional and investment communities. We certify that all the views expressed in this review, accurately reflect our personal views about Advanced Cell Technology (ACTC, Trade ) and its or their securities. No part of our compensation was, is, or will be, directly or indirectly, related to the specific recommendations or views contained in this review and we will not have any investment banking relationships or personal investment in any sponsored company. Investors are advised that this analysis and review is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy. Scimitar was paid for preparing this review. This analysis and review does not have regard to the specific investment objectives, financial situation and the information contained herein is based on sources that we believe to be reliable but is not guaranteed by us as being accurate. Any opinions expressed are statements of our own judgment as of the date of publication and are subject to change without notice. Please read all our important disclosures.
CONTACT: Scimitar Equity Research, Inc. Henry W. McCusker Director of Research phone: (617) 559-1080 fax: (617) 559-1083 e-mail: hwm*scimitarequity.com
SOURCE Scimitar Equity Research, Inc.
Henry W. McCusker for Scimitar Equity Research, Inc., Director of Research, +1-617-559-1080, or +1-617-559-1083, or hwm*scimitarequity.com
posted
Eight Companies to Present at EQUITIES 56th Anniversary Spring Conference 2007 Tuesday April 17, 7:39 pm ET
NEW YORK, NY--(MARKET WIRE)--Apr 17, 2007 -- EQUITIES Magazine proudly announces its 56th Anniversary Spring Conference 2007 to be held on Friday, April 20 at the Yale Club in New York City -- the place to be for blossoming companies looking to tell their stories to a sophisticated audience of brokers, fund managers, investment professionals and active retail investors. For over 27 years, EQUITIES has been hosting conferences connecting promising growth companies to investors. This exciting event will be moderated by David Bernard, Publisher and CEO of EQUITIES Magazine, and Victor Webb, President and Managing Director of Marston Webb International. Mr. Webb formerly served as Managing Director of Dow Jones International Marketing Services, and International Director of Dow Jones & Co., Inc.
Of the eight exciting companies presenting, four of these promising public companies are:
-- AeroGrow International (OTC BB:AGWI.OB - News), Boulder, Colorado; a company focusing on indoor aeroponic garden systems. -- Lexam Explorations (CDNX:LEX.V - News), Toronto, Canada; an energy exploration company. The company is advancing the Baca Oil & Gas Project located in Colorado, which is 75% owned by Lexam. -- Advance Cell Technology (OTC BB:ACTC.OB - News), Alameda, California; a biotechnology company engaging in the development and commercialization of human stem cell technology. -- Rocket Info (OTC BB:RKTI.OB - News), Newport Beach, California; a provider of current news and information search solutions. ADVERTISEMENT
About EQUITIES Global Communications, Inc.
EQUITIES Magazine
EQUITIES Global Communications, Inc. is a privately held corporation based in Los Angeles, CA. Covering the most exciting companies in the small and mid-cap markets, EQUITIES Magazine readers include some of the financial community's most savvy and respected investment professionals -- including corporate executives, market makers, traders, fund managers, institutional investors, portfolio managers, stockbrokers, analysts and sophisticated individual investors. In addition, EQUITIES Magazine has developed the most comprehensive investor awareness packages on the market, developing strategic marketing campaigns to help expose promising public companies to the investor marketplace. One of these programs is our EQUITIES Corporate Conferences, currently held six times a year in New York City and once in Europe. EQUITIES is also the publisher of the renowned stock advisory newsletter -- EQUITIES Special Situations, which gained over 21% from 2003 to 2006 according to The Hulbert Financial Digest.
-------------------- All post are my opinion. Do your own DD. Who's clicking your buy/sell button!? Posts: 7800 | From: Virginia | Registered: May 2006
| IP: Logged |
posted
Advanced Cell Technology's Chairman and CEO, William M. Caldwell, IV, to Present at EQUITIES 56th Anniversary Spring Conference 2007
Apr 20, 2007 08:30:28 (ET)
ALAMEDA, Calif., Apr 20, 2007 (BUSINESS WIRE) -- Advanced Cell Technology, Inc.'s (ACTC, Trade ) Chairman and Chief Executive Officer, William M. Caldwell, IV, has accepted an invitation to present at EQUITIES Magazine's 56th annual Spring Conference at the Yale Club in New York City. Mr. Caldwell's new presentation, scheduled for 11:30AM EST on Friday, April 20, 2007, will include an update on the company's achievements and plans, particularly in light of recent political developments, as general information on trends in human embryonic stem cell research and the emerging field of regenerative medicine.
A live audio web cast of this new presentation can be viewed by visiting the company's web site www.visualwebcaster.com .
About Advanced Cell Technology, Inc.
Advanced Cell Technology, Inc. is a biotechnology company applying embryonic stem cell technology in the emerging field of regenerative medicine. The company operates facilities in Alameda, California and Worcester, Massachusetts. For more information about the company, please visit http://www.advancedcell.com .
Forward-Looking Statements
Statements in this news release regarding future financial and operating results, future growth in research and development programs, potential applications of our technology, opportunities for the company and any other statements about the future expectations, beliefs, goals, plans, or prospects expressed by management constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Any statements that are not statements of historical fact (including statements containing the words "will," "believes," "plans," "anticipates," "expects," "estimates," and similar expressions) should also be considered to be forward-looking statements. There are a number of important factors that could cause actual results or events to differ materially from those indicated by such forward-looking statements, including: limited operating history, need for future capital, risks inherent in the development and commercialization of potential products, protection of our intellectual property, and economic conditions generally. Additional information on potential factors that could affect our results and other risks and uncertainties are detailed from time to time in the company's periodic reports, including the Annual Report on Form 10-KSB for the year ended December 31, 2006.
Forward-looking statements are based on the beliefs, opinions, and expectations of the company's management at the time they are made, and the company does not assume any obligation to update its forward-looking statements if those beliefs, opinions, expectations, or other circumstances should change.
SOURCE: Advanced Cell Technology, Inc.
The Investor Relations Group Investors: James Carbonara & Joseph Kessler, 212-825-3210 or Media: Bill Douglass, 212-825-3210
-------------------- LIFE IS 10% HOW YOU MAKE IT AND 90% HOW YOU TAKE IT! Posts: 9276 | From: San Diego CA | Registered: Jul 2006
| IP: Logged |
-------------------- All post are my opinion. Do your own DD. Who's clicking your buy/sell button!? Posts: 7800 | From: Virginia | Registered: May 2006
| IP: Logged |
-------------------- All post are my opinion. Do your own DD. Who's clicking your buy/sell button!? Posts: 7800 | From: Virginia | Registered: May 2006
| IP: Logged |
2007 Milestones Achieved So Far … Hired Chief Development Officer Manufacturing RPE Cells under GMP Compliant conditions Announced RPE Program Collaboration with OHSU for Preclinical Development Acquired Infigen Intellectual Property Portfolio Participated in 2007 CIRM Grants
2007-2008 Milestones To Come … Raise Additional Capital / Achieve Listing on National Exchange Announce Significant Corporate Partnership File IND for RPE Program Complete and Publish Preclinical Work for Hemangioblast and Dermal Programs Gain Approval for Federal Funding of Research Utilizing Blastomere hESC Lines Announce Scientific Breakthrough on Solving Histocompatibility
-------------------- All post are my opinion. Do your own DD. Who's clicking your buy/sell button!? Posts: 7800 | From: Virginia | Registered: May 2006
| IP: Logged |
posted
Cheers IMAKE... I thought the conference was just a slideshow so i didn't realize i missed out on the whole audio link 'till paulness mentioned something. Here is the link that works to listen.
Posted by: BooDog In reply to: Paulness who wrote msg# 6264 Date:4/20/2007 8:54:49 PM Post #of 6265
This link poped up when I clicked on www.visualwebcaster.com link from the PR posted on ACTC website. I'll send an e-mail so they can direct everyone to the right place. The link from the PR's from yahoo didn't work - sent me to a calendar.
-------------------- All post are my opinion. Do your own DD. Who's clicking your buy/sell button!? Posts: 7800 | From: Virginia | Registered: May 2006
| IP: Logged |
posted
ACTC and other stem cell comps will move higher as we head toward next election. Once Bush adminst out of office these bills will be pushed through imo.
Posts: 11 | From: austin,tx,us | Registered: Aug 2000
| IP: Logged |
-------------------- All post are my opinion. Do your own DD. Who's clicking your buy/sell button!? Posts: 7800 | From: Virginia | Registered: May 2006
| IP: Logged |
-------------------- All post are my opinion. Do your own DD. Who's clicking your buy/sell button!? Posts: 7800 | From: Virginia | Registered: May 2006
| IP: Logged |